OTC

Strength

15; 400; 60 mg/1; mg/1; mg/1

Manufacturer

Capital Pharma

NDC

29978060190

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/18/2017

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/20/2013

Pharmacological Classes

Adrenergic alpha-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+1.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.